Offer - Urjas Oil for just ₹ 1 X
Nitroprin 60/75 Tablet is a prescription drug, available for use as Tablet. Primarily, it is used for the treatment of Angina, Fever, Heart Attack. Secondary and off-label uses of Nitroprin 60/75 Tablet have also been mentioned below.
The optimal dosage of Nitroprin 60/75 Tablet is largely dependent on the individual's body weight, medical history, gender and age. Dosage also depends on the route of administration and your chief complaint for which the drug is prescribed. This information has been provided in detail in the dosage section.
The most common side effects of Nitroprin 60/75 Tablet are Headache, Dizziness, Flushing. Some other side effects of Nitroprin 60/75 Tablet have been listed ahead. These side effects of Nitroprin 60/75 Tablet are usually temporary and subside with the completion of treatment. However, if these continue for a longer time, consult your doctor right away.
In addition, Nitroprin 60/75 Tablet's effect is Severe during pregnancy and Severe for lactating mothers. In addition, Nitroprin 60/75 Tablet's effects on the liver, heart and kidney are discussed below in the Nitroprin 60/75 Tablet related warnings section.
Nitroprin 60/75 Tablet can cause adverse effects in certain medical conditions. It is strongly recommended to avoid Nitroprin 60/75 Tablet in conditions like Low Blood Pressure (Hypotension), Anemia, Asthma. The section on Nitroprin 60/75 Tablet contraindications lists all such conditions.
Drug interactions for Nitroprin 60/75 Tablet have been reported in the medical literature. See below for a complete list.
In addition to these precautions, you may also note that Nitroprin 60/75 Tablet is safe while driving, and is is addictive in nature.
Nitroprin 60/75 Tablet is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Is the use of Nitroprin 60/75 Tablet safe for pregnant women?
Nitroprin should not be taken during pregnancy, or should only be taken on the advice of a doctor as it may have severe side effects.
Is the use of Nitroprin 60/75 Tablet safe during breastfeeding?
Nitroprin should not be taken without taking your doctor's advice, as it may have severe side effects on breastfeeding women.
What is the effect of Nitroprin 60/75 Tablet on the Kidneys?
Nitroprin can have moderate side effects on the kidney. If you notice any harmful effects, stop taking this drug right away. Consult your doctor before using this medicine again.
What is the effect of Nitroprin 60/75 Tablet on the Liver?
Nitroprin is not harmful for the liver.
What is the effect of Nitroprin 60/75 Tablet on the Heart?
The heart can be affected by Nitroprin. If you experience any unwanted effects of this drug, stop taking it and consult your doctor. You should restart the medicine only after medical advice.
Nitroprin 60/75 Tablet should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Nitroprin 60/75 Tablet unless your doctor advises you to do so -
Is this Nitroprin 60/75 Tablet habit forming or addictive?
Nitroprin 60/75 Tablet does not cause addiction.
Interaction between Food and Nitroprin 60/75 Tablet
Due to a lack of research, nothing can be said about the consequences of taking Nitroprin 60/75 Tablet together with food.
Interaction between Alcohol and Nitroprin 60/75 Tablet
Due to lack of research, there is no information about the side effects of taking Nitroprin 60/75 Tablet with alcohol.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; monoket® (isosorbide mononitrate)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 544
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 716-718
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Durlaza (aspirin)
KD Tripathi. Essentials of Medical Pharmacology. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 195-199
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 191-194